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INTRODUCTION
Benign biliary strictures are traditionally treated surgically 
but, due to the significant associated morbidity and 
mortality (1, 2), less invasive percutaneous and endoscopic 
methods are often used. Endoscopic treatment may be 
difficult, particularly in patients with a surgically altered 
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Objective: To evaluate the effect of temporary stent graft placement in the treatment of benign anastomotic biliary strictures. 
Materials and Methods: Nine patients, five women and four men, 22-64 years old (mean, 47.5 years), with chronic benign 
biliary anastomotic strictures, refractory to repeated balloon dilations, were treated by prolonged, temporary placement of 
stent-grafts. Four patients had strictures following a liver transplantation; three of them in bilio-enteric anastomoses and 
one in a choledocho-choledochostomy. Four of the other five patients had strictures at bilio-enteric anastomoses, which 
developed after complications following laparoscopic cholecystectomies and in one after a Whipple procedure for duodenal 
carcinoma. In eight patients, balloon-expandable stent-grafts were placed and one patient was treated by insertion of a 
self-expanding stent-graft.
Results: In the transplant group, treatment of patients with bilio-enteric anastomoses was unsuccessful (mean stent 
duration, 30 days). The patient treated for stenosis in the choledocho-choledochostomy responded well to consecutive self-
expanding stent-graft placement (total placement duration, 112 days). All patients with bilio-enteric anastomoses in the 
non-transplant group were treated successfully with stent-grafts (mean placement duration, 37 days).
Conclusion: Treatment of benign biliary strictures with temporary placement of stent-grafts has a positive effect, but is 
less successful in patients with strictures developed following a liver transplant.
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anatomy. Percutaneous access is the remaining alternative 
and allows repeated balloon dilatations to be performed. 
If these dilations are unsuccessful, patients often need 
permanent internal/external biliary catheter drainage which 
is uncomfortable and requires frequent catheter changes. 
Bare metal stents have limited long term patency (3-5) due 
to epithelial hyperplasia and may preclude future surgical 
procedures (5-7). We present our experience with temporary 
placement of stent-grafts, with the aim of keeping the 
strictured segments expanded for a longer period of time, 
possibly preventing recurrence of the stricture.
MATERIALS AND METHODS
Approval for this retrospective analysis was obtained from 
our Institutional Review Board and informed consent was 
waived. Korean J Radiol 12(6), Nov/Dec 2011 kjronline.org 709
Temporary Placement of Stent Grafts in Postsurgical Benign Biliary Strictures
Patients 
Nine patients, five females, and four males aged between 
22 and 64 years old (mean, 47.5 years), were treated. 
Four patients had anastomotic strictures following liver 
transplantation performed for primary sclerosing cholangitis 
(n = 2), hepatocellular carcinoma (n = 1), and a large 
arteriovenous malformation causing heart failure (n = 1). Of 
the remaining five patients, four had strictures at the bilio-
enteric anastomoses that occurred as a result of bile duct 
injury at laparoscopic cholecystectomy, and one developed a 
stricture many years after a Whipple procedure for duodenal 
carcinoma. 
All patients required percutaneous placement of 
permanent internal/external biliary drainage due to stenoses 
at the surgical anastomoses. In all of these patients (Table 
1), the anastomotic strictures failed repeated prolonged 
(over five minutes) balloon dilations on at least three 
occasions.
Treatment
Following informed consent, all procedures were 
performed under conscious sedation and with administration 
of the local anesthesia. The existing biliary drainage 
catheter was removed over a guide wire, and replaced with 
a 7-9 Fr vascular sheath; cholangiograms were obtained in 
multiple projections and measurements were performed.
In the eight patients with bilio-enteric anastomoses, 
7-9 mm diameter I-cast
TM balloon-expandable stent-grafts 
(Atrium, Hudson, NH) were placed (Fig. 1). The stent-
graft was un-mounted from the balloon and cut to the 
appropriate length (0.5 cm longer than the length of the 
stricture). Before placement, the stent graft was remounted 
onto an 8-10 mm diameter, 20-40 mm long balloon, and 
deployed across the strictures under fluoroscopic guidance. 
In the one patient with the choledocho-choledochal 
anastomosis (post liver transplant), a more flexible 9 mm 
diameter Viabahn self-expanding stent-graft (W. L. Gore & 
Associates, Inc. Flagstaff, AZ) was used (Fig. 2). We expected 
that this stent-graft might be easier to retrieve or dislodge 
to the bowel, than a balloon-expandable stent-graft.
Follow Up
After placement, an 8 Fr internal/external biliary drain 
was inserted through the stent graft and was capped. 
Patients returned for cholangiograms in 2-8 weeks (mean, 
33 days). At this time, some of the balloon-expandable 
stent-grafts had already migrated to the bowel, and 
the others were pushed into the bowel using a dilation 
balloon. The self-expanding stent graft had migrated from 
the anastomosis in the proximal direction, but could be 
uneventfully removed. 
Table 1. Patient Demographics and History
Patient Gender Age (Y) Transplant Anastomotic Type
A M 59 Y HJ
B M 51 Y Chol-Chol
C M 60 Y HJ
D F 55 Y CJ
E M 38 N CJ
F F 64 N CJ
G F 22 N HJ
H F 24 N HJ x 2
I F 55 N HJ
Note.— Chol-Chol =
 choledocho-choledochostomy, CJ = 
choledochojejunostomy, HJ = hepaticojejunostomy, Y = years
A B C
Fig. 1. Stent graft in postsurgical benign biliary stricture. 
A. 46-year-old male patient following liver transplant with tight stenosis (arrow) at choledocho-choledochostomy. B. Placement of 9 mm self-
expanding stent (Viabahn) across the stricture (arrow). C. Two months after placement, stent graft is pushed into bowel and there is free flow of 
contrast from biliary tree to bowel (arrow).Korean J Radiol 12(6), Nov/Dec 2011 kjronline.org 710
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If the absence of a significant stricture was noted on 
cholangiography, the internal/external biliary drains were 
converted to external drainage only. The drainage catheters 
were left above the anastomosis and capped for a period 
of four to six weeks. At this time, liver function tests were 
checked and the cholangiography repeated. If good outflow 
was confirmed, then the catheters were removed. Patients 
were thereafter followed with liver function tests.
In the presence of insufficient flow through the 
anastomotic segment, another stent graft was placed for an 
additional period of time (4-6 weeks). 
RESULTS
Results are summarized in Table 2.
In the three liver transplant patients with bilio-enteric 
anastomoses, stent grafts were left in place for an average 
of 30 days. Two of these patients required repeated stent 
graft placement. Stent graft migration at the time of the 
first follow up was noted in one of these three patients. 
None of these patients could be treated successfully and all 
required permanent internal/external biliary drainage. 
In the transplant patient, with the choledocho-
choledochostomy, the first stent graft, left in place for 50 
days, migrated in the proximal direction and was removed 
through a sheath using a snare. A second stent graft 
remained in place for 63 days and subsequently dislodged 
to the bowel with a dilation balloon. The treatment was 
successful and the patient remained stable with normal 
laboratory values at 22 months follow-up. 
A B C
Fig. 2. Stent graft in postsurgical benign biliary stricture.
A. Tight stricture (arrow) at hepaticojejunostomy in 38-year-old patient with bile duct injury following cholecystectomy. B. Placement of 8 mm 
stent-graft (I-cast) across stricture (arrow). C. Stent is pushed into bowel after 10 weeks, revealing patent anastomosis with free flow of contrast 
on subsequent cholangiogram (arrow).
Table 2. Results
Patient








A 2 10 mm I-cast/10 mm I-cast 17/38 N/N N N/A
B 2 9 mm Viabahn 50/63 Y/N Y 22
C 2 8 mm I-cast/10 mm I-cast 36/31 Y/Y N N/A
D 1 10 mm I-cast 29 N N N/A
E 2 8 mm I-cast/10 mm I-cast 42/14 Y/N Y 21
F 1 10 mm I-cast 31  N Y 7
G 1 10 mm I-cast 55 N Y 12
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Of the five other patients, totaling six bilio-enteric 
anastomoses (one patient had two separate anastomoses), 
three were treated with a single stent-graft placement. Of 
these three, one stent graft had migrated to the bowel at 
the time of follow up, but the stricture remained properly 
dilated. The remaining two patients were treated with 
repeated stent graft placements following the migration of 
the first one. Each course lasted between 14 and 55 days 
with a mean of 37 days. Treatment was successful in all 
these five patients. One patient was lost at follow-up, but 
the other four remained tube free with stable laboratory 
values at 4, 7, 12, and 21 months respectively.
DISCUSSION
An increased number of liver transplants and laparoscopic 
cholecystectomies during recent years, have been followed 
by an increased number of patients with benign anastomotic 
strictures. Surgical revision of these strictures can be 
difficult and is associated with significant morbidity rate of 
approximately 25%, and a mortality rate of 2-13% (1, 2), 
requiring increased length of hospital stay. Furthermore, in 
a subset of patients with cirrhosis, portal hypertension, and 
malnutrition, the risks of surgery are even more significant 
(8, 9). Before surgical revision, endoscopic or percutaneous 
approaches to treat the stricture are usually attempted. 
Following the establishment of adequate biliary drainage to 
relieve the patient’s symptoms, repeated balloon dilation 
of the stricture was attempted. The endoscopic approach 
is, however, often difficult or not possible in the majority 
of patients with bilio-enteric anastomoses; and as a result, 
percutaneous access is most commonly used.
Success rates of balloon dilatation range from 62% to 
83% with mean follow-up periods of 24-36 months (10-
13). Balloon dilatation appears to be more effective in 
bile duct strictures related to injuries from laparoscopic 
cholecystectomies than in anastomotic strictures (14). 
A patency rate of 71% was achieved in patients with 
postoperative strictures treated with a combination of 
balloon dilatation and prolonged drainage with silicon tubes 
calibrated up to 15 French. Duration of tube placement was 
one year and the median follow-up time was 34 months (15). 
The use of cutting balloons also showed encouraging results 
with long-term patency rates of as much as 90% (16-19).
The efficacy of placement of biliary endoprostheses 
in patients with benign biliary strictures was evaluated 
in several studies, but many disadvantages were noted. 
Notably, endoscopically placed plastic stents had limited 
patency, could migrate (20), and were usually occluded 
within three to six months, requiring replacement (21). 
Percutaneously placed plastic stents also require relatively 
large access through the liver, thus increasing the 
possibility of complications.
The use of bare metal stents is associated with long 
term failure due to mucosal hyperplasia (22) and these 
stents cannot be removed. Stent grafts have been 
shown to remain patent for a longer period of time than 
bare stents in malignant disease (23-25), and may be 
removed (26, 27). In a series of 44 patients with chronic 
pancreatitis, gallstone-related strictures, post liver 
transplant, autoimmune pancreatitis, and primary sclerosing 
cholangitis, 10 mm stent grafts were placed endoscopically 
with resolution of the stricture in 83% of cases. The median 
length of stent treatment was 3.3 months (28). During the 
removal of these stents, mucosal bleeding was seen in 43% 
of patients. This was likely related to the stent design, 
which was tailored to preventing migration. Placement was 
also technically challenging due to the rigid delivery system 
of the stent (Viabil, W. L. Gore & Associates, Inc. Flagstaff, 
AZ).
In a series of 79 patients with benign bile duct strictures, 
the placement of partially covered metal stents for a 
median of four months resulted in the resolution of the 
strictures in 90% of cases (29). Stent migration was seen in 
11% of cases and strictures related to mucosal hyperplasia 
in 8% of cases. Partially covered Wallstents were used 
in a series of 20 patients with biliary strictures due to 
chronic pancreatitis (30). Stents were left in place for a 
median of five months. Persistent stricture resolution at 
six months after stent removal was seen in 90% of cases. 
Longer term follow up at a median of 22 months revealed 
two further patients who needed repeat stent placement 
and consequently, 80% remained free from strictures. In 
a series of 14 patients with strictures related to chronic 
pancreatitis, in whom partially covered Wallstents were 
placed, seven were found to be complicated by tissue 
hyperplasia or migration at a median of 22 months (31). 
The literature describing the percutaneous placement 
of self-expanding stent-grafts is limited. Gwon et al. (32) 
report a series of 29 patients with cholangitis or post-
operative strictures who had covered custom-made stents 
placed percutaneously for a mean of seven weeks. Three 
patients required additional stent-grafts due to recurrent 
strictures. At a mean of 28 months after removal of the Korean J Radiol 12(6), Nov/Dec 2011 kjronline.org 712
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stent-grafts, the patency rate was 97%. Stent-grafts also 
prevented the ingrowth of tissue and could be retrieved 
(32, 33). However, self-expanding stent-grafts are relatively 
long, making them difficult to place in a short anastomotic 
stricture. Balloon-expandable stent-grafts as used in 
our study in all but one patient, can be cut easily to an 
appropriate length, facilitating its exact deployment.
The findings in our cases suggest that temporary 
placement of stent grafts has a better effect in non-
transplant patients than in the transplant patients. All 
six of the anastomotic strictures in the non-transplant 
patients responded to the treatment. In the post-transplant 
group, none of the patients with bilio-enteric anastomoses 
responded, however the patient with a choledocho-
choledochostomy, did respond. The failure of treatment in 
bilioenteric anastomoses may be secondary to the altered 
blood supply after liver transplantation. The ischemia 
may be less pronounced in the case of a duct-to-duct 
anastomosis. Secondarily, failure may have resulted from 
too brief a treatment duration. Short treatment durations 
were used in our study at the beginning (two weeks), but 
were successively extended (up to 8 weeks) as patients 
tolerated the stents being in place well. Better results 
may have been achieved in the biliary enteric anastomotic 
transplant patients had the stent grafts been left in place 
for even longer periods of time. 
Stent graft migration was seen in two of our patients 
from the transplant group and three from the non-transplant 
group, as has been reported previously (34). However, in 
our study, stent graft migration did not have an impact on 
the success of the therapy.
Limitations of our study include the small number of 
patients, the retrospective nature of the study, and the 
heterogeneity in the management of patients. In addition, 
in the cases where stent graft migration occurred, it 
is impossible to know for how long the device actually 
remained in the intended position. 
We may conclude that treatment was successful in the 
non-transplant patients, but failed in the liver transplant 
patients with bilio-digestive anastomoses. 
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